Purified anti-human CD161 Recombinant Antibody, CD161, QA20B14,BioLegend,379502

Host

Mouse

Reactivity

Human

Application

FC - Quality tested

Platform ID

BAB458025773

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-human CD161 Recombinant Antibody, CD161, QA20B14
Cat. No.379502
HostMouse
RRIDAB_2910447 (BioLegend Cat. No. 379502)
IsotypeMouse IgG1, κ
ReactivityHuman
ApplicationFC - Quality tested
ClonalityRecombinant
Clone NumberQA20B14
Concentration0.5 mg/mL
TargetCD161
ImmunogenHuman NK cells
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

CD161, also known as NKR-P1A, is a type II transmembrane glycoprotein that is expressed as a 40-44 kD homodimer. It is a member of the C-type lectin superfamily. CD161 is expressed on a majority of NK cells, NKT cells, and subsets of peripheral T cells and CD3+ thymocytes. It has been reported that Th17 cells are a subpopulation of CD4+CD161+CCR6+ cells. While the biological function of CD161 is not clear, it has been suggested to serve either as a stimulatory receptor or to inhibit NK cell-mediated cytotoxicity and cytokine production. LLT-1 (lectin-like transcript-1), also known as osteoclast inhibitory lectin or CLEC2D, is the ligand of CD161.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.